- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01789996
The Six Minute Walk Test: Influence of Instruction on Results
June 12, 2020 updated by: Inova Health Care Services
Alternative Instruction in Six Minute Walk Test (6MWT)
Two - four 6MWT performed according to ATS standards.
Each walk however had specifically altered wording and coaching performed in random order to determine differences in outcomes.
One walk was done in the standard ATS fashion.
One was done coaching to walk as fast as the patient can walk.
One was coached to walk at the patients normal walking pace.
One was coached to walk at the patient's leisure walking pace.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Alternate 6MWT where subjects will be asked to walk as fast as they can, walk as normal as they can and walk leisurely as they can in 6 minutes compared to standard of care 6MWT which is walk as far as you can in 6 minutes.
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Virginia
-
Falls Church, Virginia, United States, 22042
- Inova Advanced Lung Disease and Transplant Program
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- advanced lung disease such as COPD, ILD, IPF, or PAH
Exclusion Criteria:
- inability to walk, requiring supplemental oxygen, cardiac disease preventing successful 6MWT
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Alternative six minute walk test
Subjects will be given the following instructions
|
Alternate instructions will be given Subjects will
Other Names:
|
Placebo Comparator: Standard six minute walk test
Subjects will be given the following instruction 1. walk as far as they can in 6 minutes |
Subjects will walk as far as they can in 6 minutes
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
distance meters
Time Frame: 1 day
|
this is an ongoing study of same day testing of 2-4 six minute walk tests, each with different instructions, to determine the impact of alternative instruction on outcome of the test
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
oxygen saturation
Time Frame: 1 day
|
assessed as an outcome of variable instruction given in different six minute walk tests performed in random order on the same day
|
1 day
|
dyspnea score
Time Frame: 1 day
|
assessed as an outcome of variable instruction given in different six minute
|
1 day
|
heart rate response
Time Frame: 1 day
|
assessed as an outcome of variable instruction given in different six minute
|
1 day
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
heart rate recovery at one minute
Time Frame: 1 day
|
assessed as an outcome of variable instruction given in different six minute
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Steven D Nathan, MD, Inova Advanced Lung Disease and Transplant Program
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2010
Primary Completion (Actual)
November 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
February 9, 2013
First Submitted That Met QC Criteria
February 9, 2013
First Posted (Estimate)
February 12, 2013
Study Record Updates
Last Update Posted (Actual)
June 16, 2020
Last Update Submitted That Met QC Criteria
June 12, 2020
Last Verified
August 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10.089
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
We found that when the instruction was given to walk as fast as they can in six minutes, the distance was statistically greater than when the instruction was to walk as far as they can in six minutes.
THe other instructions given yielded no difference in outcome.
Other measures such are heart rate, Borg dyspnea score and saturation were not as statistically significant.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Interstitial Lung Disease
-
Boehringer IngelheimNo longer availableLung Diseases, Interstitial (in Pediatric Populations) | Childhood Interstitial Lung Disease (chILD)
-
Matthias GrieseSuspendedInterstitial Lung Disease | Diffuse Parenchymal Lung Disease | Children´s Interstitial Lung DiseaseGermany
-
University of AlbertaAlberta Boehringer Ingelheim CollaborationNot yet recruitingFibrotic Interstitial Lung Disease
-
Monash UniversityRecruitingFibrotic Interstitial Lung DiseaseAustralia
-
Heidelberg UniversityHelmholtz Zentrum München; University of Giessen; Lungenfibrose e.V.; German Center... and other collaboratorsCompletedInterstitial Lung Disease (ILD)Germany
-
University of California, San FranciscoTerminatedFibrotic Interstitial Lung DiseaseUnited States
-
Saglik Bilimleri UniversitesiRecruitingTelerehabilitation | Fibrosing Interstitial Lung DiseaseTurkey
-
University of AarhusAarhus University HospitalNot yet recruitingProgressive Fibrosing Interstitial Lung DiseaseDenmark
-
West Virginia UniversityNot yet recruitingProgressive Fibrosing Interstitial Lung DiseaseUnited States
Clinical Trials on alternative six minute walk test
-
Faculdades Metropolitanas UnidasCompleted
-
Universidade Federal de PernambucoCompletedObstructive Sleep ApneaBrazil
-
Foundation University IslamabadHasselt UniversityUnknownOsteoarthritis | Osteoarthritis, KneePakistan
-
Concordia University, St. PaulCompletedPhysical Activity | Rehabilitation | Functional CapacityUnited States
-
University Hospital, BrestMinistry of Health, FranceCompleted
-
Creighton UniversityCompleted
-
National Heart Centre SingaporeDuke-NUS Graduate Medical SchoolCompletedCardiovascular Disease OtherSingapore
-
McGill University Health Centre/Research Institute...UnknownNoncardiac Surgery | Risk Assessment | Postoperative Myocardial Infarction | Postoperative DeathCanada
-
University of FloridaTerminatedChronic Obstructive Pulmonary Disease | Alpha-1 Antitrypsin DeficiencyUnited States
-
Gazi UniversityCompletedMultiple SclerosisTurkey